{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:05:35Z","timestamp":1785207935312,"version":"3.55.0"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10072-025-08023-y","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T23:38:51Z","timestamp":1738453131000},"page":"2419-2436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u201cAdvances in biomarker discovery and diagnostics for alzheimer\u2019s disease\u201d"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-7192","authenticated-orcid":false,"given":"Vandana","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Chandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavnika","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"1","key":"8023_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS et al (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Primers"},{"key":"8023_CR2","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK (2021) Alzheimer\u2019s disease and its treatment by different approaches: A review. Eur J Med Chem 216:113320. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113320","journal-title":"Eur J Med Chem"},{"issue":"10","key":"8023_CR3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","volume":"76","author":"CR Jack","year":"2019","unstructured":"Jack CR et al (2019) Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging\u2013Alzheimer\u2019s Association Research Framework. JAMA Neurol 76(10):1174. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1971","journal-title":"JAMA Neurol"},{"issue":"1","key":"8023_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-Onset Alzheimer\u2019s Disease Is Associated With Greater Pathologic Burden. J Geriatr Psychiatry Neurol 20(1):29\u201333. https:\/\/doi.org\/10.1177\/0891988706297086","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3\u20134","key":"8023_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000504341","volume":"48","author":"ML Phillips","year":"2019","unstructured":"Phillips ML et al (2019) Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer\u2019s Disease Subjects: Evidence for Disease Heterogeneity. Dement Geriatr Cogn Disord 48(3\u20134):131\u2013142. https:\/\/doi.org\/10.1159\/000504341","journal-title":"Dement Geriatr Cogn Disord"},{"key":"8023_CR6","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.bspc.2021.103293","volume":"72","author":"G Mirzaei","year":"2022","unstructured":"Mirzaei G, Adeli H (2022) Machine learning techniques for diagnosis of alzheimer disease, mild cognitive disorder, and other types of dementia. Biomed Signal Process Control 72:103293. https:\/\/doi.org\/10.1016\/j.bspc.2021.103293","journal-title":"Biomed Signal Process Control"},{"issue":"1","key":"8023_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/dx-2015-0031","volume":"3","author":"KG Baker","year":"2016","unstructured":"Baker KG (2016) Evaluation of DSM-5 and IWG-2 criteria for the diagnosis of Alzheimer\u2019s disease and dementia with Lewy bodies. Diagnosis 3(1):9\u201312. https:\/\/doi.org\/10.1515\/dx-2015-0031","journal-title":"Diagnosis"},{"key":"8023_CR8","doi-asserted-by":"publisher","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013)The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & dementia 9(1):63\u201375. https:\/\/doi.org\/10.1016\/j.jalz.2012.11.007","DOI":"10.1016\/j.jalz.2012.11.007"},{"key":"8023_CR9","doi-asserted-by":"publisher","unstructured":"\u201cFEATURES,\u201d (2012) Asia Pac Biotech News, 16(10-11): 22\u201338. https:\/\/doi.org\/10.1142\/S0219030312000651","DOI":"10.1142\/S0219030312000651"},{"issue":"1","key":"8023_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"8023_CR11","doi-asserted-by":"publisher","unstructured":"Jack Jr CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E (2018) NIA\u2010AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's & dementia 14(4):535\u201362.\u00a0https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"8023_CR12","doi-asserted-by":"publisher","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia 7(3):263\u20139.\u00a0https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","DOI":"10.1016\/j.jalz.2011.03.005"},{"issue":"4","key":"8023_CR13","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE (2012) Brain Imaging in Alzheimer Disease. Cold Spring Harb Perspect Med 2(4):a006213\u2013a006213. https:\/\/doi.org\/10.1101\/cshperspect.a006213","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"8023_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS et al (2005) The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc 53(4):695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"8023_CR15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/ijms24021659","volume":"24","author":"RV Rao","year":"2023","unstructured":"Rao RV et al (2023) Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer\u2019s Disease and MCI: A Review. Int J Mol Sci 24(2):1659. https:\/\/doi.org\/10.3390\/ijms24021659","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8023_CR16","doi-asserted-by":"publisher","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","volume":"2","author":"S Weintraub","year":"2012","unstructured":"Weintraub S, Wicklund AH, Salmon DP (2012) The Neuropsychological Profile of Alzheimer Disease. Cold Spring Harb Perspect Med 2(4):a006171\u2013a006171. https:\/\/doi.org\/10.1101\/cshperspect.a006171","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"8023_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"7","key":"8023_CR18","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","volume":"48","author":"A Leuzy","year":"2021","unstructured":"Leuzy A et al (2021) A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging 48(7):2295\u20132305. https:\/\/doi.org\/10.1007\/s00259-021-05401-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"8023_CR19","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/alz.12356","volume":"17","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Hansson O (2021) Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 17(12):1998\u20132008. https:\/\/doi.org\/10.1002\/alz.12356","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"8023_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","volume":"69","author":"P Buchhave","year":"2012","unstructured":"Buchhave P (2012) Cerebrospinal Fluid Levels of\u03b2-Amyloid 1\u201342, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia. Arch Gen Psychiatry 69(1):98. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.155","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"8023_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaneurol.2018.0118","volume":"75","author":"A Lle\u00f3","year":"2018","unstructured":"Lle\u00f3 A et al (2018) A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. JAMA Neurol 75(6):738. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0118","journal-title":"JAMA Neurol"},{"issue":"1","key":"8023_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S et al (2017) Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun 8(1):1214. https:\/\/doi.org\/10.1038\/s41467-017-01150-x","journal-title":"Nat Commun"},{"key":"8023_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","volume":"7","author":"J Weller","year":"2018","unstructured":"Weller J, Budson A (2018) Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res 7:1161. https:\/\/doi.org\/10.12688\/f1000research.14506.1","journal-title":"F1000Res"},{"issue":"1","key":"8023_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.trci.2019.06.001","volume":"5","author":"R Wittenberg","year":"2019","unstructured":"Wittenberg R, Knapp M, Karagiannidou M, Dickson J, Schott JM (2019) Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer\u2019s disease patients. Alzheimer\u2019s Dement Trans Res Clin Interv 5(1):382\u2013387. https:\/\/doi.org\/10.1016\/j.trci.2019.06.001","journal-title":"Alzheimer\u2019s Dement Trans Res Clin Interv"},{"issue":"7","key":"8023_CR25","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/brain\/awaa165","volume":"143","author":"KAQ Cousins","year":"2020","unstructured":"Cousins KAQ et al (2020) ATN status in amnestic and non-amnestic Alzheimer\u2019s disease and frontotemporal lobar degeneration. Brain 143(7):2295\u20132311. https:\/\/doi.org\/10.1093\/brain\/awaa165","journal-title":"Brain"},{"issue":"1","key":"8023_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O\u2019Bryant","year":"2017","unstructured":"O\u2019Bryant SE et al (2017) Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer\u2019s Dementia 13(1):45\u201358. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.014","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"4","key":"8023_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti D et al (2014) Circulating miRNAs as Potential Biomarkers in Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis 42(4):1261\u20131267. https:\/\/doi.org\/10.3233\/JAD-140756","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"8023_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbrc.2016.08.067","volume":"483","author":"PH Reddy","year":"2017","unstructured":"Reddy PH et al (2017) A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer\u2019s disease. Biochem Biophys Res Commun 483(4):1156\u20131165. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.067","journal-title":"Biochem Biophys Res Commun"},{"issue":"46","key":"8023_CR29","doi-asserted-by":"publisher","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","volume":"31","author":"PC May","year":"2011","unstructured":"May PC et al (2011) Robust Central Reduction of Amyloid-\u03b2 in Humans with an Orally Available, Non-Peptidic \u03b2-Secretase Inhibitor. J Neurosci 31(46):16507\u201316516. https:\/\/doi.org\/10.1523\/JNEUROSCI.3647-11.2011","journal-title":"J Neurosci"},{"issue":"3","key":"8023_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55(3):306\u2013319. https:\/\/doi.org\/10.1002\/ana.20009","journal-title":"Ann Neurol"},{"issue":"5","key":"8023_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","volume":"126","author":"CR Jack","year":"2013","unstructured":"Jack CR, Barrio JR, Kepe V (2013) Cerebral amyloid PET imaging in Alzheimer\u2019s disease. Acta Neuropathol 126(5):643\u2013657. https:\/\/doi.org\/10.1007\/s00401-013-1185-7","journal-title":"Acta Neuropathol"},{"issue":"2","key":"8023_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe CC et al (2008) Imaging of amyloid \u03b2 in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 7(2):129\u2013135. https:\/\/doi.org\/10.1016\/S1474-4422(08)70001-2","journal-title":"Lancet Neurol"},{"issue":"8","key":"8023_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","volume":"50","author":"N Nelissen","year":"2009","unstructured":"Nelissen N et al (2009) Phase 1 Study of the Pittsburgh Compound B Derivative 18 F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease. J Nucl Med 50(8):1251\u20131259. https:\/\/doi.org\/10.2967\/jnumed.109.063305","journal-title":"J Nucl Med"},{"issue":"6","key":"8023_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2967\/jnumed.112.114785","volume":"54","author":"CC Rowe","year":"2013","unstructured":"Rowe CC et al (2013) Head-to-Head Comparison of 11 C-PiB and 18 F-AZD4694 (NAV4694) for \u03b2-Amyloid Imaging in Aging and Dementia. J Nucl Med 54(6):880\u2013886. https:\/\/doi.org\/10.2967\/jnumed.112.114785","journal-title":"J Nucl Med"},{"issue":"6393","key":"8023_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C et al (1992) Amyloid \u03b2-peptide is produced by cultured cells during normal metabolism. Nature 359(6393):322\u2013325. https:\/\/doi.org\/10.1038\/359322a0","journal-title":"Nature"},{"issue":"7","key":"8023_CR36","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1073\/pnas.89.7.2551","volume":"89","author":"WE Van Nostrand","year":"1992","unstructured":"Van Nostrand WE et al (1992) Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci 89(7):2551\u20132555. https:\/\/doi.org\/10.1073\/pnas.89.7.2551","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"8023_CR37","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1006\/bbrc.1994.1634","volume":"200","author":"M Tabaton","year":"1994","unstructured":"Tabaton M, Nunzi MG, Xue R, Usiak M, Autiliogambetti L, Gambetti P (1994) Soluble Amyloid \u03b2-Protein Is a Marker of Alzheimer Amyloid in Brain But Not in Cerebrospinal Fluid. Biochem Biophys Res Commun 200(3):1598\u20131603. https:\/\/doi.org\/10.1006\/bbrc.1994.1634","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"8023_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: Evidence that an initially deposited species is A\u03b242(43). Neuron 13(1):45\u201353. https:\/\/doi.org\/10.1016\/0896-6273(94)90458-8","journal-title":"Neuron"},{"issue":"18","key":"8023_CR39","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT (1993) The carboxy terminus of the.beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer\u2019s disease. Biochemistry 32(18):4693\u20134697. https:\/\/doi.org\/10.1021\/bi00069a001","journal-title":"Biochemistry"},{"issue":"4","key":"8023_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R et al (1995) Reduction of \u03b2-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38(4):643\u2013648. https:\/\/doi.org\/10.1002\/ana.410380413","journal-title":"Ann Neurol"},{"issue":"2","key":"8023_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A et al (2005) Simultaneous Measurement of \u03b2-Amyloid(1\u201342), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology. Clin Chem 51(2):336\u2013345. https:\/\/doi.org\/10.1373\/clinchem.2004.039347","journal-title":"Clin Chem"},{"issue":"3","key":"8023_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J et al (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated A\u03b2 peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81(3):481\u2013496. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00818.x","journal-title":"J Neurochem"},{"key":"8023_CR43","doi-asserted-by":"publisher","unstructured":"Zetterberg H et al., (2008) \u201cElevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease\u201d. Arch Neurol 65(8), https:\/\/doi.org\/10.1001\/archneur.65.8.1102","DOI":"10.1001\/archneur.65.8.1102"},{"issue":"6","key":"8023_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N et al (1999) Cerebrospinal Fluid \u03b2-Amyloid(1\u201342) in Alzheimer Disease. Arch Neurol 56(6):673. https:\/\/doi.org\/10.1001\/archneur.56.6.673","journal-title":"Arch Neurol"},{"issue":"7","key":"8023_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1373\/clinchem.2013.220392","volume":"60","author":"A Leinenbach","year":"2014","unstructured":"Leinenbach A et al (2014) Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-\u03b2 in Cerebrospinal Fluid. Clin Chem 60(7):987\u2013994. https:\/\/doi.org\/10.1373\/clinchem.2013.220392","journal-title":"Clin Chem"},{"issue":"10","key":"8023_CR46","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2(10):605\u2013613. https:\/\/doi.org\/10.1016\/S1474-4422(03)00530-1","journal-title":"Lancet Neurol"},{"issue":"3","key":"8023_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0361-9230(03)00086-8","volume":"61","author":"K Blennow","year":"2003","unstructured":"Blennow K, Vanmechelen E (2003) CSF markers for pathogenic processes in Alzheimer\u2019s disease: diagnostic implications and use in clinical neurochemistry. Brain Res Bull 61(3):235\u2013242. https:\/\/doi.org\/10.1016\/S0361-9230(03)00086-8","journal-title":"Brain Res Bull"},{"issue":"4","key":"8023_CR48","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/pr050475v","volume":"5","author":"E Portelius","year":"2006","unstructured":"Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K (2006) Determination of \u03b2-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass Spectrometry. J Proteome Res 5(4):1010\u20131016. https:\/\/doi.org\/10.1021\/pr050475v","journal-title":"J Proteome Res"},{"issue":"5","key":"8023_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000100926","volume":"23","author":"O Hansson","year":"2007","unstructured":"Hansson O et al (2007) Prediction of Alzheimer\u2019s Disease Using the CSF A\u03b242\/A\u03b240 Ratio in Patients with Mild Cognitive Impairment. Dement Geriatr Cogn Disord 23(5):316\u2013320. https:\/\/doi.org\/10.1159\/000100926","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"8023_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttil\u00e4 T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM (2000) Plasma and Cerebrospinal Fluid Levels of Amyloid \u03b2 Proteins 1\u201340 and 1\u201342 in Alzheimer Disease. Arch Neurol 57(1):100. https:\/\/doi.org\/10.1001\/archneur.57.1.100","journal-title":"Arch Neurol"},{"issue":"4","key":"8023_CR51","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","volume":"101","author":"J Wiltfang","year":"2007","unstructured":"Wiltfang J et al (2007) Amyloid \u03b2 peptide ratio 42\/40 but not A\u03b242 correlates with phospho-Tau in patients with low- and high-CSF A\u03b240 load. J Neurochem 101(4):1053\u20131059. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04404.x","journal-title":"J Neurochem"},{"issue":"8","key":"8023_CR52","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/aww139","volume":"139","author":"BA Gordon","year":"2016","unstructured":"Gordon BA et al (2016) The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain 139(8):2249\u20132260. https:\/\/doi.org\/10.1093\/brain\/aww139","journal-title":"Brain"},{"key":"8023_CR53","doi-asserted-by":"publisher","unstructured":"Brier MR et al., (2016) \u201cTau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease\u201d. Sci Transl Med, 8(338) https:\/\/doi.org\/10.1126\/scitranslmed.aaf2362","DOI":"10.1126\/scitranslmed.aaf2362"},{"issue":"9","key":"8023_CR54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0000000000003050","volume":"87","author":"JP Chhatwal","year":"2016","unstructured":"Chhatwal JP et al (2016) Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly. Neurology 87(9):920\u2013926. https:\/\/doi.org\/10.1212\/WNL.0000000000003050","journal-title":"Neurology"},{"key":"8023_CR55","doi-asserted-by":"publisher","unstructured":"Khan SS, and Bloom GS (2016) \u201cTau: The Center of a Signaling Nexus in Alzheimer\u2019s Disease\u201d. Front Neurosci 10, https:\/\/doi.org\/10.3389\/fnins.2016.00031","DOI":"10.3389\/fnins.2016.00031"},{"issue":"1","key":"8023_CR56","doi-asserted-by":"publisher","first-page":"a006437","DOI":"10.1101\/cshperspect.a006437","volume":"1","author":"VM-Y Lee","year":"2011","unstructured":"Lee VM-Y, Brunden KR, Hutton M, Trojanowski JQ (2011) Developing Therapeutic Approaches to Tau, Selected Kinases, and Related Neuronal Protein Targets. Cold Spring Harb Perspect Med 1(1):a006437\u2013a006437. https:\/\/doi.org\/10.1101\/cshperspect.a006437","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4994","key":"8023_CR57","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"VMY Lee","year":"1991","unstructured":"Lee VMY, Balin BJ, Otvos L, Trojanowski JQ (1991) A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau. Science 251(4994):675\u2013678. https:\/\/doi.org\/10.1126\/science.1899488","journal-title":"Science"},{"issue":"6","key":"8023_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B et al (2014) Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol 13(6):614\u2013629. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0","journal-title":"Lancet Neurol"},{"issue":"3","key":"8023_CR59","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1515\/CCLM.2011.086","volume":"49","author":"AC van Harten","year":"2011","unstructured":"van Harten AC et al (2011) Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. cclm 49(3):353\u2013366. https:\/\/doi.org\/10.1515\/CCLM.2011.086","journal-title":"cclm"},{"issue":"6","key":"8023_CR60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL et al (2018) Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol 136(6):821\u2013853. https:\/\/doi.org\/10.1007\/s00401-018-1932-x","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8023_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, \u00c5gren H, Spenger C, Siegfried J, Vanmechelen E (1995) tau protein in cerebrospinal fluid. Mol Chem Neuropathol 26(3):231\u2013245. https:\/\/doi.org\/10.1007\/BF02815140","journal-title":"Mol Chem Neuropathol"},{"issue":"1","key":"8023_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E et al (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285(1):49\u201352. https:\/\/doi.org\/10.1016\/S0304-3940(00)01036-3","journal-title":"Neurosci Lett"},{"issue":"3","key":"8023_CR63","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","volume":"287","author":"R Kohnken","year":"2000","unstructured":"Kohnken R et al (2000) Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer\u2019s disease patients. Neurosci Lett 287(3):187\u2013190. https:\/\/doi.org\/10.1016\/S0304-3940(00)01178-2","journal-title":"Neurosci Lett"},{"issue":"7","key":"8023_CR64","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"issue":"5","key":"8023_CR65","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M et al (2016) PET Imaging of Tau Deposition in the Aging Human Brain. Neuron 89(5):971\u2013982. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028","journal-title":"Neuron"},{"issue":"2","key":"8023_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H et al (2016) In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol 80(2):247\u2013258. https:\/\/doi.org\/10.1002\/ana.24711","journal-title":"Ann Neurol"},{"issue":"5","key":"8023_CR67","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ et al (2016) Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139(5):1539\u20131550. https:\/\/doi.org\/10.1093\/brain\/aww023","journal-title":"Brain"},{"issue":"4","key":"8023_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"issue":"4","key":"8023_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"2","key":"8023_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67\u201377. https:\/\/doi.org\/10.1038\/nrneurol.2009.215","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"8023_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.42.1.183","volume":"42","author":"CR Jack","year":"1992","unstructured":"Jack CR, Petersen RC, O\u2019Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer\u2019s disease. Neurology 42(1):183\u2013183. https:\/\/doi.org\/10.1212\/WNL.42.1.183","journal-title":"Neurology"},{"issue":"9170","key":"8023_CR72","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(99)00496-1","volume":"353","author":"NC Fox","year":"1999","unstructured":"Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer\u2019s disease. The Lancet 353(9170):2125. https:\/\/doi.org\/10.1016\/S0140-6736(99)00496-1","journal-title":"The Lancet"},{"issue":"16","key":"8023_CR73","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","volume":"76","author":"BC Dickerson","year":"2011","unstructured":"Dickerson BC et al (2011) Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76(16):1395\u20131402. https:\/\/doi.org\/10.1212\/WNL.0b013e3182166e96","journal-title":"Neurology"},{"issue":"5","key":"8023_CR74","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/cercor\/bhz286","volume":"30","author":"NM Vogt","year":"2020","unstructured":"Vogt NM et al (2020) Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer\u2019s Disease Dementia. Cereb Cortex 30(5):2948\u20132960. https:\/\/doi.org\/10.1093\/cercor\/bhz286","journal-title":"Cereb Cortex"},{"issue":"7","key":"8023_CR75","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol 76(7):791. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0765","journal-title":"JAMA Neurol"},{"issue":"12","key":"8023_CR76","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.3390\/ijms19123702","volume":"19","author":"GD Femminella","year":"2018","unstructured":"Femminella GD et al (2018) Imaging and Molecular Mechanisms of Alzheimer\u2019s Disease: A Review. Int J Mol Sci 19(12):3702. https:\/\/doi.org\/10.3390\/ijms19123702","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8023_CR77","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1212\/01.wnl.0000228243.56665.c2","volume":"67","author":"M Bozzali","year":"2006","unstructured":"Bozzali M et al (2006) The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 67(3):453\u2013460. https:\/\/doi.org\/10.1212\/01.wnl.0000228243.56665.c2","journal-title":"Neurology"},{"issue":"10","key":"8023_CR78","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/brain\/awm213","volume":"130","author":"S Alladi","year":"2007","unstructured":"Alladi S et al (2007) Focal cortical presentations of Alzheimer\u2019s disease. Brain 130(10):2636\u20132645. https:\/\/doi.org\/10.1093\/brain\/awm213","journal-title":"Brain"},{"issue":"10","key":"8023_CR79","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","volume":"71","author":"JL Whitwell","year":"2008","unstructured":"Whitwell JL et al (2008) MRI correlates of neurofibrillary tangle pathology at autopsy. Neurology 71(10):743\u2013749. https:\/\/doi.org\/10.1212\/01.wnl.0000324924.91351.7d","journal-title":"Neurology"},{"issue":"5","key":"8023_CR80","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/13803390600826579","volume":"29","author":"MA Fearing","year":"2007","unstructured":"Fearing MA et al (2007) Autopsy-confirmed Alzheimer\u2019s disease versus clinically diagnosed Alzheimer\u2019s disease in the Cache County Study on Memory and Aging: A comparison of quantitative MRI and neuropsychological findings. J Clin Exp Neuropsychol 29(5):553\u2013560. https:\/\/doi.org\/10.1080\/13803390600826579","journal-title":"J Clin Exp Neuropsychol"},{"issue":"6","key":"8023_CR81","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1212\/01.WNL.0000154530.72969.11","volume":"64","author":"AF Fotenos","year":"2005","unstructured":"Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL (2005) Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 64(6):1032\u20131039. https:\/\/doi.org\/10.1212\/01.WNL.0000154530.72969.11","journal-title":"Neurology"},{"issue":"1","key":"8023_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12877-019-1072-8","volume":"19","author":"M Wei","year":"2019","unstructured":"Wei M et al (2019) A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer\u2019s disease in a Chinese population. BMC Geriatr 19(1):59. https:\/\/doi.org\/10.1186\/s12877-019-1072-8","journal-title":"BMC Geriatr"},{"issue":"9","key":"8023_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11910-014-0475-3","volume":"14","author":"S Suri","year":"2014","unstructured":"Suri S, Topiwala A, Mackay CE, Ebmeier KP, Filippini N (2014) Using Structural and Diffusion Magnetic Resonance Imaging To Differentiate the Dementias. Curr Neurol Neurosci Rep 14(9):475. https:\/\/doi.org\/10.1007\/s11910-014-0475-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"8023_CR84","doi-asserted-by":"publisher","unstructured":"Vernooij MW, and van Buchem MA (2020) \u201cNeuroimaging in Dementia\u201d 131\u2013142 https:\/\/doi.org\/10.1007\/978-3-030-38490-6_11","DOI":"10.1007\/978-3-030-38490-6_11"},{"issue":"1","key":"8023_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0197-4580(02)00045-3","volume":"24","author":"M Boccardi","year":"2003","unstructured":"Boccardi M (2003) The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia. Neurobiol Aging 24(1):95\u2013103. https:\/\/doi.org\/10.1016\/S0197-4580(02)00045-3","journal-title":"Neurobiol Aging"},{"issue":"1","key":"8023_CR86","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40478-019-0842-z","volume":"7","author":"M Quintas-Neves","year":"2019","unstructured":"Quintas-Neves M et al (2019) Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART). Acta Neuropathol Commun 7(1):204. https:\/\/doi.org\/10.1186\/s40478-019-0842-z","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"8023_CR87","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1002\/hbm.24782","volume":"40","author":"A Chandra","year":"2019","unstructured":"Chandra A, Valkimadi P, Pagano G, Cousins O, Dervenoulas G, Politis M (2019) Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer\u2019s disease and mild cognitive impairment. Hum Brain Mapp 40(18):5424\u20135442. https:\/\/doi.org\/10.1002\/hbm.24782","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"8023_CR88","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/diagnostics9020065","volume":"9","author":"S Suppiah","year":"2019","unstructured":"Suppiah S, Didier M-A, Vinjamuri S (2019) The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer\u2019s Disease\u2014Review of Literature and Interesting Images. Diagnostics 9(2):65. https:\/\/doi.org\/10.3390\/diagnostics9020065","journal-title":"Diagnostics"},{"issue":"1","key":"8023_CR89","doi-asserted-by":"publisher","first-page":"W76","DOI":"10.2214\/AJR.13.12363","volume":"204","author":"VKN Shivamurthy","year":"2015","unstructured":"Shivamurthy VKN, Tahari AK, Marcus C, Subramaniam RM (2015) Brain FDG PET and the Diagnosis of Dementia. Am J Roentgenol 204(1):W76\u2013W85. https:\/\/doi.org\/10.2214\/AJR.13.12363","journal-title":"Am J Roentgenol"},{"issue":"4","key":"8023_CR90","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD et al (1991) Physical basis of cognitive alterations in alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580. https:\/\/doi.org\/10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"issue":"4","key":"8023_CR91","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease. Eur J Nucl Med Mol Imaging 32(4):486\u2013510. https:\/\/doi.org\/10.1007\/s00259-005-1762-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"8023_CR92","first-page":"1441","volume":"86","author":"S Xiao","year":"2006","unstructured":"Xiao S, Xue H, Li G, Li C, Wu W, Zhang M (2006) Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases. Zhonghua Yi Xue Za Zhi 86(21):1441\u20131446","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"8023_CR93","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1148\/rg.343135065","volume":"34","author":"RKJ Brown","year":"2014","unstructured":"Brown RKJ, Bohnen NI, Wong KK, Minoshima S, Frey KA (2014) Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism. Radiographics 34(3):684\u2013701. https:\/\/doi.org\/10.1148\/rg.343135065","journal-title":"Radiographics"},{"issue":"7","key":"8023_CR94","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jalz.2019.03.016","volume":"15","author":"VJ Lowe","year":"2019","unstructured":"Lowe VJ et al (2019) Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. Alzheimer\u2019s & Dementia 15(7):927\u2013939. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.016","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"8023_CR95","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","volume":"39","author":"C Marcus","year":"2014","unstructured":"Marcus C, Mena E, Subramaniam RM (2014) Brain PET in the Diagnosis of Alzheimer\u2019s Disease. Clin Nucl Med 39(10):e413\u2013e426. https:\/\/doi.org\/10.1097\/RLU.0000000000000547","journal-title":"Clin Nucl Med"},{"issue":"23","key":"8023_CR96","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","volume":"77","author":"GD Rabinovici","year":"2011","unstructured":"Rabinovici GD et al (2011) Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology 77(23):2034\u20132042. https:\/\/doi.org\/10.1212\/WNL.0b013e31823b9c5e","journal-title":"Neurology"},{"issue":"2","key":"8023_CR97","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.25968","volume":"89","author":"OH Lesman-Segev","year":"2021","unstructured":"Lesman-Segev OH et al (2021) Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in <scp>Autopsy-Confirmed<\/scp> Dementia. Ann Neurol 89(2):389\u2013401. https:\/\/doi.org\/10.1002\/ana.25968","journal-title":"Ann Neurol"},{"issue":"3","key":"8023_CR98","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S, Foster NL, Sima AAF, Frey KA, Albin RL, Kuhl DE (2001) Alzheimer\u2019s disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50(3):358\u2013365. https:\/\/doi.org\/10.1002\/ana.1133","journal-title":"Ann Neurol"},{"issue":"10","key":"8023_CR99","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain 130(10):2616\u20132635. https:\/\/doi.org\/10.1093\/brain\/awm177","journal-title":"Brain"},{"key":"8023_CR100","doi-asserted-by":"publisher","first-page":"621","DOI":"10.54097\/hset.v36i.5745","volume":"36","author":"S Wang","year":"2023","unstructured":"Wang S (2023) The Progression of Current Biomarkers for the Diagnosis of Alzheimer\u2019s Disease. Highlights Sci Eng Technol 36:621\u2013627. https:\/\/doi.org\/10.54097\/hset.v36i.5745","journal-title":"Highlights Sci Eng Technol"},{"key":"8023_CR101","doi-asserted-by":"publisher","unstructured":"Marvi F, Chen YH, and Sawan M (2024) \u201cAlzheimer\u2019s Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia\u201d. IEEE Rev Biomed Eng 1\u201318, https:\/\/doi.org\/10.1109\/RBME.2024.3376835","DOI":"10.1109\/RBME.2024.3376835"},{"issue":"4","key":"8023_CR102","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.21917\/ijivp.2024.0463","volume":"14","author":"M Rajalakshmi","year":"2024","unstructured":"Rajalakshmi M, Karthik C (2024) A deep learning-based framework for alzheimer\u2019s disease diagnosis and progression prediction from mri images. ICTACT J Image Video Process 14(4):3251\u20133257. https:\/\/doi.org\/10.21917\/ijivp.2024.0463","journal-title":"ICTACT J Image Video Process"},{"issue":"1","key":"8023_CR103","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3233\/ADR-230150","volume":"8","author":"I-L De Guia","year":"2024","unstructured":"De Guia I-L, Eslick S, Naismith SL, Kanduri S, Shah TM, Martins RN (2024) The Crosstalk Between Amyloid-\u03b2, Retina, and Sleep for the Early Diagnosis of Alzheimer\u2019s Disease: A Narrative Review. J Alzheimers Dis Rep 8(1):1009\u20131021. https:\/\/doi.org\/10.3233\/ADR-230150","journal-title":"J Alzheimers Dis Rep"},{"issue":"4","key":"8023_CR104","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3233\/JAD-200888","volume":"78","author":"S de Fuente Garcia la","year":"2020","unstructured":"de Fuente Garcia la S, Ritchie CW, Luz S (2020) Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer\u2019s Disease: A Systematic Review. J Alzheimer\u2019s Dis 78(4):1547\u20131574. https:\/\/doi.org\/10.3233\/JAD-200888","journal-title":"J Alzheimer\u2019s Dis"},{"key":"8023_CR105","doi-asserted-by":"publisher","unstructured":"Hl DS, Thomas SM, (2024) \u201cA Multimodal Approach Integrating Convolutional and Recurrent Neural Networks for Alzheimer\u2019s Disease Temporal Progression Prediction\u201d. in 2024 IEEE\/CVF Conf Comput Vis Patt Recog Workshops (CVPRW), 5207\u20135215. https:\/\/doi.org\/10.1109\/CVPRW63382.2024.00529","DOI":"10.1109\/CVPRW63382.2024.00529"},{"issue":"9","key":"8023_CR106","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ et al (2012) Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease. N Engl J Med 367(9):795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"8023_CR107","doi-asserted-by":"publisher","unstructured":"McDade E et al., (2018) \u201cLongitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease\u201d. Neurology, 91(14), https:\/\/doi.org\/10.1212\/WNL.0000000000006277","DOI":"10.1212\/WNL.0000000000006277"},{"issue":"S1","key":"8023_CR108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K Blennow","year":"2017","unstructured":"Blennow K (2017) A Review of Fluid Biomarkers for Alzheimer\u2019s Disease: Moving from CSF to Blood. Neurol Ther 6(S1):15\u201324. https:\/\/doi.org\/10.1007\/s40120-017-0073-9","journal-title":"Neurol Ther"},{"issue":"3","key":"8023_CR109","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1212\/CON.0000000000001083","volume":"28","author":"SE Schindler","year":"2022","unstructured":"Schindler SE (2022) Fluid Biomarkers in Dementia Diagnosis. CONTINUUM Lifelong Learn Neurol 28(3):822\u2013833. https:\/\/doi.org\/10.1212\/CON.0000000000001083","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"issue":"18","key":"8023_CR110","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel H et al (2023) Blood-based biomarkers for Alzheimer\u2019s disease: Current state and future use in a transformed global healthcare landscape. Neuron 111(18):2781\u20132799. https:\/\/doi.org\/10.1016\/j.neuron.2023.05.017","journal-title":"Neuron"},{"issue":"3","key":"8023_CR111","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ et al (2024) Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol 81(3):255. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319","journal-title":"JAMA Neurol"},{"issue":"5","key":"8023_CR112","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","volume":"11","author":"SE O\u2019Bryant","year":"2015","unstructured":"O\u2019Bryant SE et al (2015) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research. Alzheimer\u2019s Dementia 11(5):549\u2013560. https:\/\/doi.org\/10.1016\/j.jalz.2014.08.099","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"5","key":"8023_CR113","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.25334","volume":"84","author":"IMW Verberk","year":"2018","unstructured":"Verberk IMW et al (2018) Plasma Amyloid as Prescreener for the Earliest <scp>A<\/scp> lzheimer Pathological Changes. Ann Neurol 84(5):648\u2013658. https:\/\/doi.org\/10.1002\/ana.25334","journal-title":"Ann Neurol"},{"issue":"12","key":"8023_CR114","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1002\/alz.13390","volume":"19","author":"LM Winchester","year":"2023","unstructured":"Winchester LM et al (2023) Artificial intelligence for biomarker discovery in Alzheimer\u2019s disease and dementia. Alzheimer\u2019s & Dementia 19(12):5860\u20135871. https:\/\/doi.org\/10.1002\/alz.13390","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"9","key":"8023_CR115","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR, Vergallo A (2021) Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 17(9):580\u2013589. https:\/\/doi.org\/10.1038\/s41582-021-00520-w","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"8023_CR116","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O et al (2022) The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 18(12):2669\u20132686. https:\/\/doi.org\/10.1002\/alz.12756","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"8","key":"8023_CR117","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V Ovod","year":"2017","unstructured":"Ovod V et al (2017) Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer\u2019s Dementia 13(8):841\u2013849. https:\/\/doi.org\/10.1016\/j.jalz.2017.06.2266","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"17","key":"8023_CR118","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE et al (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93(17):2019. https:\/\/doi.org\/10.1212\/WNL.0000000000008081","journal-title":"Neurology"},{"issue":"7691","key":"8023_CR119","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A et al (2018) High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature 554(7691):249\u2013254. https:\/\/doi.org\/10.1038\/nature25456","journal-title":"Nature"},{"issue":"10","key":"8023_CR120","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O et al (2018) The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: A review. Alzheimer\u2019s Dementia 14(10):1313\u20131333. https:\/\/doi.org\/10.1016\/j.jalz.2018.05.008","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"3","key":"8023_CR121","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-170773","volume":"62","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) The Past and the Future of Alzheimer\u2019s Disease Fluid Biomarkers. J Alzheimer\u2019s Dis 62(3):1125\u20131140. https:\/\/doi.org\/10.3233\/JAD-170773","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"9","key":"8023_CR122","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S et al (2019) Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related \u03b2-Amyloid Status. JAMA Neurol 76(9):1060. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1632","journal-title":"JAMA Neurol"},{"issue":"1","key":"8023_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","volume":"10","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P et al (2018) Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease. Alzheimers Res Ther 10(1):71. https:\/\/doi.org\/10.1186\/s13195-018-0404-9","journal-title":"Alzheimers Res Ther"},{"key":"8023_CR124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","volume":"262","author":"D Rufino-Ramos","year":"2017","unstructured":"Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, Pereira de Almeida L (2017) Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. J Control Release 262:247\u2013258. https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.001","journal-title":"J Control Release"},{"issue":"7","key":"8023_CR125","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/ijms20071728","volume":"20","author":"S Lee","year":"2019","unstructured":"Lee S, Mankhong S, Kang J-H (2019) Extracellular Vesicle as a Source of Alzheimer\u2019s Biomarkers: Opportunities and Challenges. Int J Mol Sci 20(7):1728. https:\/\/doi.org\/10.3390\/ijms20071728","journal-title":"Int J Mol Sci"},{"key":"8023_CR126","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","volume":"106","author":"D Chiasserini","year":"2014","unstructured":"Chiasserini D et al (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset. J Proteomics 106:191\u2013204. https:\/\/doi.org\/10.1016\/j.jprot.2014.04.028","journal-title":"J Proteomics"},{"issue":"4","key":"8023_CR127","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/jnc.14635","volume":"151","author":"EM Cilento","year":"2019","unstructured":"Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J (2019) Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurochem 151(4):397\u2013416. https:\/\/doi.org\/10.1111\/jnc.14635","journal-title":"J Neurochem"},{"issue":"2","key":"8023_CR128","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10930-009-9227-7","volume":"29","author":"G Maccarrone","year":"2010","unstructured":"Maccarrone G, Turck CW, Martins-de-Souza D (2010) Shotgun Mass Spectrometry Workflow Combining IEF and LC-MALDI-TOF\/TOF. Protein J 29(2):99\u2013102. https:\/\/doi.org\/10.1007\/s10930-009-9227-7","journal-title":"Protein J"},{"issue":"4","key":"8023_CR129","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3233\/JAD-2012-121471","volume":"33","author":"J Pannee","year":"2013","unstructured":"Pannee J et al (2013) A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A\u03b238, A\u03b240, and A\u03b242 in Cerebrospinal Fluid of Alzheimer\u2019s Disease Patients and Healthy Controls. J Alzheimer\u2019s Dis 33(4):1021\u20131032. https:\/\/doi.org\/10.3233\/JAD-2012-121471","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"8023_CR130","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou M et al (2020) Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteomics 17(1):19. https:\/\/doi.org\/10.1186\/s12014-020-09285-8","journal-title":"Clin Proteomics"},{"issue":"1","key":"8023_CR131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H et al (2020) Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener 15(1):43. https:\/\/doi.org\/10.1186\/s13024-020-00384-6","journal-title":"Mol Neurodegener"},{"key":"8023_CR132","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","volume":"8","author":"E Trushina","year":"1842","unstructured":"Trushina E, Mielke MM (1842) (2014) \u201cRecent advances in the application of metabolomics to Alzheimer\u2019s Disease.\u201d Biochimica et Biophys Acta (BBA) - Mol Basis Dis 8:1232\u20131239. https:\/\/doi.org\/10.1016\/j.bbadis.2013.06.014","journal-title":"Biochimica et Biophys Acta (BBA) - Mol Basis Dis"},{"key":"8023_CR133","doi-asserted-by":"publisher","unstructured":"Wilkins JM, and Trushina E, (2018) \u201cApplication of Metabolomics in Alzheimer\u2019s Disease\u201d. Front Neurol, 8 https:\/\/doi.org\/10.3389\/fneur.2017.00719","DOI":"10.3389\/fneur.2017.00719"},{"issue":"18","key":"8023_CR134","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4155\/bio-2018-0135","volume":"10","author":"MO Hurtado","year":"2018","unstructured":"Hurtado MO, Kohler I, de Lange ECM (2018) Next-Generation Biomarker Discovery in Alzheimer\u2019s Disease Using Metabolomics \u2013 from Animal to Human Studies. Bioanalysis 10(18):1525\u20131546. https:\/\/doi.org\/10.4155\/bio-2018-0135","journal-title":"Bioanalysis"},{"issue":"1","key":"8023_CR135","doi-asserted-by":"publisher","first-page":"170140","DOI":"10.1038\/sdata.2017.140","volume":"4","author":"L St John-Williams","year":"2017","unstructured":"St John-Williams L et al (2017) Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Sci Data 4(1):170140. https:\/\/doi.org\/10.1038\/sdata.2017.140","journal-title":"Sci Data"},{"issue":"1","key":"8023_CR136","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","volume":"10","author":"HM Snyder","year":"2014","unstructured":"Snyder HM et al (2014) Developing novel blood-based biomarkers for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 10(1):109\u2013114. https:\/\/doi.org\/10.1016\/j.jalz.2013.10.007","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"8023_CR137","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1021\/acs.jproteome.5b01020","volume":"15","author":"G Paglia","year":"2016","unstructured":"Paglia G et al (2016) Unbiased Metabolomic Investigation of Alzheimer\u2019s Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism. J Proteome Res 15(2):608\u2013618. https:\/\/doi.org\/10.1021\/acs.jproteome.5b01020","journal-title":"J Proteome Res"},{"issue":"2","key":"8023_CR138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","volume":"81","author":"J Moffett","year":"2007","unstructured":"Moffett J, Ross B, Arun P, Madhavarao C, Namboodiri A (2007) N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog Neurobiol 81(2):89\u2013131. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.12.003","journal-title":"Prog Neurobiol"},{"issue":"2","key":"8023_CR139","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ene.12879","volume":"23","author":"A Willette","year":"2016","unstructured":"Willette A (2016) Does metabolic syndrome impact cognition and emotion in <scp>A<\/scp> lzheimer\u2019s disease? Eur J Neurol 23(2):237\u2013238. https:\/\/doi.org\/10.1111\/ene.12879","journal-title":"Eur J Neurol"},{"issue":"6","key":"8023_CR140","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10522-013-9479-7","volume":"14","author":"LA Demetrius","year":"2013","unstructured":"Demetrius LA, Driver J (2013) Alzheimer\u2019s as a metabolic disease. Biogerontology 14(6):641\u2013649. https:\/\/doi.org\/10.1007\/s10522-013-9479-7","journal-title":"Biogerontology"},{"key":"8023_CR141","doi-asserted-by":"publisher","unstructured":"\u201c2022 Alzheimer\u2019s disease facts and figures\u201d. Alzheimer\u2019s Dementia, 18(4): 700\u2013789, https:\/\/doi.org\/10.1002\/alz.12638","DOI":"10.1002\/alz.12638"},{"key":"8023_CR142","doi-asserted-by":"publisher","first-page":"108661","DOI":"10.1016\/j.biopha.2019.108661","volume":"113","author":"PR Manzine","year":"2019","unstructured":"Manzine PR et al (2019) ADAM10 in Alzheimer\u2019s disease: Pharmacological modulation by natural compounds and its role as a peripheral marker. Biomed Pharmacother 113:108661. https:\/\/doi.org\/10.1016\/j.biopha.2019.108661","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"8023_CR143","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/opo.12675","volume":"40","author":"TJ Heesterbeek","year":"2020","unstructured":"Heesterbeek TJ, Lor\u00e9s-Motta L, Hoyng CB, Lechanteur YTE, den Hollander AI (2020) Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt 40(2):140\u2013170. https:\/\/doi.org\/10.1111\/opo.12675","journal-title":"Ophthalmic Physiol Opt"},{"key":"8023_CR144","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","volume":"190","author":"R Loera-Valencia","year":"2019","unstructured":"Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S (2019) Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: Potential novel targets for treatment. J Steroid Biochem Mol Biol 190:104\u2013114. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.03.003","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"8023_CR145","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3233\/JAD-215311","volume":"86","author":"H Cao","year":"2022","unstructured":"Cao H et al (2022) Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer\u2019s Disease Risk. J Alzheimer\u2019s Dis 86(4):1861\u20131873. https:\/\/doi.org\/10.3233\/JAD-215311","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"8023_CR146","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/glia.23968","volume":"69","author":"J Wi\u00dffeld","year":"2021","unstructured":"Wi\u00dffeld J et al (2021) Deletion of Alzheimer\u2019s disease-associated <scp>CD33<\/scp> results in an inflammatory human microglia phenotype. Glia 69(6):1393\u20131412. https:\/\/doi.org\/10.1002\/glia.23968","journal-title":"Glia"},{"key":"8023_CR147","doi-asserted-by":"publisher","unstructured":"Liu X, Jiao B, and Shen L, (2018) \u201cThe Epigenetics of Alzheimer\u2019s Disease: Factors and Therapeutic Implications\u201d. Front Genet, 9 https:\/\/doi.org\/10.3389\/fgene.2018.00579","DOI":"10.3389\/fgene.2018.00579"},{"issue":"5","key":"8023_CR148","doi-asserted-by":"publisher","first-page":"a019133","DOI":"10.1101\/cshperspect.a019133","volume":"6","author":"E Li","year":"2014","unstructured":"Li E, Zhang Y (2014) DNA Methylation in Mammals. Cold Spring Harb Perspect Biol 6(5):a019133\u2013a019133. https:\/\/doi.org\/10.1101\/cshperspect.a019133","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"8023_CR149","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13072-017-0150-4","volume":"10","author":"MA Christopher","year":"2017","unstructured":"Christopher MA, Kyle SM, Katz DJ (2017) Neuroepigenetic mechanisms in disease. Epigenetics Chromatin 10(1):47. https:\/\/doi.org\/10.1186\/s13072-017-0150-4","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"8023_CR150","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4161\/epi.28741","volume":"9","author":"V Patil","year":"2014","unstructured":"Patil V, Ward RL, Hesson LB (2014) The evidence for functional non-CpG methylation in mammalian cells. Epigenetics 9(6):823\u2013828. https:\/\/doi.org\/10.4161\/epi.28741","journal-title":"Epigenetics"},{"issue":"7","key":"8023_CR151","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41576-022-00456-x","volume":"23","author":"K Boulias","year":"2022","unstructured":"Boulias K, Greer EL (2022) Means, mechanisms and consequences of adenine methylation in DNA. Nat Rev Genet 23(7):411\u2013428. https:\/\/doi.org\/10.1038\/s41576-022-00456-x","journal-title":"Nat Rev Genet"},{"key":"8023_CR152","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.coph.2021.07.014","volume":"60","author":"D Bano","year":"2021","unstructured":"Bano D, Salomoni P, Ehninger D, Nicotera P (2021) The histone code in dementia: Transcriptional and chromatin plasticity fades away. Curr Opin Pharmacol 60:117\u2013122. https:\/\/doi.org\/10.1016\/j.coph.2021.07.014","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"8023_CR153","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2217\/nmt-2018-0004","volume":"8","author":"A Stoccoro","year":"2018","unstructured":"Stoccoro A, Copped\u00e8 F (2018) Role of Epigenetics in Alzheimer\u2019s Disease Pathogenesis. Neurodegener Dis Manag 8(3):181\u2013193. https:\/\/doi.org\/10.2217\/nmt-2018-0004","journal-title":"Neurodegener Dis Manag"},{"key":"8023_CR154","doi-asserted-by":"publisher","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C, (2018) \u201cOverview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation\u201d. Front Endocrinol (Lausanne), 9 https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"issue":"22","key":"8023_CR155","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.3390\/ijms20225573","volume":"20","author":"X Zhang","year":"2019","unstructured":"Zhang X et al (2019) Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci 20(22):5573. https:\/\/doi.org\/10.3390\/ijms20225573","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8023_CR156","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrneurol.2014.1","volume":"10","author":"H Malkki","year":"2014","unstructured":"Malkki H (2014) Chaperone protein clusterin is involved in amyloid-\u03b2-associated entorhinal atrophy in early AD. Nat Rev Neurol 10(2):60\u201360. https:\/\/doi.org\/10.1038\/nrneurol.2014.1","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"8023_CR157","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.drudis.2016.05.005","volume":"21","author":"DN Rocha","year":"2016","unstructured":"Rocha DN, Carvalho ED, P\u00eago AP (2016) High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases. Drug Discov Today 21(9):1355\u20131366. https:\/\/doi.org\/10.1016\/j.drudis.2016.05.005","journal-title":"Drug Discov Today"},{"issue":"10","key":"8023_CR158","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1021\/acsptsci.4c00457","volume":"7","author":"RR Doke","year":"2024","unstructured":"Doke RR, Lamkhade GJ, Vinchurkar K, Singh S (2024) Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer\u2019s Disease: A Review. ACS Pharmacol Transl Sci 7(10):2987\u20133003. https:\/\/doi.org\/10.1021\/acsptsci.4c00457","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"8023_CR159","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1038\/srep02364","volume":"3","author":"K Inoue","year":"2013","unstructured":"Inoue K et al (2013) Metabolic profiling of Alzheimer\u2019s disease brains. Sci Rep 3(1):2364. https:\/\/doi.org\/10.1038\/srep02364","journal-title":"Sci Rep"},{"key":"8023_CR160","doi-asserted-by":"publisher","unstructured":"Morgan K, and Carrasquillo MM, Eds., Genetic Variants in Alzheimer\u2019s Disease. New York, NY: Springer New York, 2013. https:\/\/doi.org\/10.1007\/978-1-4614-7309-1","DOI":"10.1007\/978-1-4614-7309-1"},{"issue":"8","key":"8023_CR161","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jalz.2017.01.015","volume":"13","author":"DR Roalf","year":"2017","unstructured":"Roalf DR et al (2017) Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimer\u2019s Dementia 13(8):947\u2013952. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.015","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"8","key":"8023_CR162","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41583-019-0196-3","volume":"20","author":"JW Fawcett","year":"2019","unstructured":"Fawcett JW, Oohashi T, Pizzorusso T (2019) The roles of perineuronal nets and the perinodal extracellular matrix in neuronal function. Nat Rev Neurosci 20(8):451\u2013465. https:\/\/doi.org\/10.1038\/s41583-019-0196-3","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"8023_CR163","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2009-1177","volume":"18","author":"K Blennow","year":"2009","unstructured":"Blennow K, Zetterberg H (2009) Cerebrospinal Fluid Biomarkers for Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis 18(2):413\u2013417. https:\/\/doi.org\/10.3233\/JAD-2009-1177","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"8","key":"8023_CR164","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.3390\/ijms22083933","volume":"22","author":"T Soares Martins","year":"2021","unstructured":"Soares Martins T et al (2021) Exosomal A\u03b2-Binding Proteins Identified by \u2018In Silico\u2019 Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer\u00b4s Disease. Int J Mol Sci 22(8):3933. https:\/\/doi.org\/10.3390\/ijms22083933","journal-title":"Int J Mol Sci"},{"issue":"5","key":"8023_CR165","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1007\/s12035-022-02762-1","volume":"59","author":"T Soares Martins","year":"2022","unstructured":"Soares Martins T et al (2022) Novel Exosome Biomarker Candidates for Alzheimer\u2019s Disease Unravelled Through Mass Spectrometry Analysis. Mol Neurobiol 59(5):2838\u20132854. https:\/\/doi.org\/10.1007\/s12035-022-02762-1","journal-title":"Mol Neurobiol"},{"key":"8023_CR166","doi-asserted-by":"publisher","unstructured":"Toden S et al., (2020) \u201cNoninvasive characterization of Alzheimer\u2019s disease by circulating, cell-free messenger RNA next-generation sequencing\u201d. Sci Adv, 6(50) https:\/\/doi.org\/10.1126\/sciadv.abb1654","DOI":"10.1126\/sciadv.abb1654"},{"issue":"6","key":"8023_CR167","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jagp.2020.10.012","volume":"29","author":"AP Rajkumar","year":"2021","unstructured":"Rajkumar AP et al (2021) Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies. Am J Geriatric Psychiatry 29(6):573\u2013584. https:\/\/doi.org\/10.1016\/j.jagp.2020.10.012","journal-title":"Am J Geriatric Psychiatry"},{"issue":"1","key":"8023_CR168","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jagp.2019.06.007","volume":"28","author":"AP Rajkumar","year":"2020","unstructured":"Rajkumar AP et al (2020) Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation. Am J Geriatr Psychiatry 28(1):75\u201386. https:\/\/doi.org\/10.1016\/j.jagp.2019.06.007","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"8023_CR169","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1109\/TMI.2019.2935916","volume":"39","author":"P Qian","year":"2020","unstructured":"Qian P et al (2020) mDixon-Based Synthetic CT Generation for PET Attenuation Correction on Abdomen and Pelvis Jointly Using Transfer Fuzzy Clustering and Active Learning-Based Classification. IEEE Trans Med Imaging 39(4):819\u2013832. https:\/\/doi.org\/10.1109\/TMI.2019.2935916","journal-title":"IEEE Trans Med Imaging"},{"key":"8023_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.patcog.2019.03.032","volume":"93","author":"JM G\u00f3rriz","year":"2019","unstructured":"G\u00f3rriz JM, Ramirez J, Suckling J (2019) On the computation of distribution-free performance bounds: Application to small sample sizes in neuroimaging. Pattern Recognit 93:1\u201313. https:\/\/doi.org\/10.1016\/j.patcog.2019.03.032","journal-title":"Pattern Recognit"},{"key":"8023_CR171","doi-asserted-by":"publisher","unstructured":"Venugopalan J, Tong L, Hassanzadeh HR, and Wang MD, (2021) \u201cMultimodal deep learning models for early detection of Alzheimer\u2019s disease stage\u201d. Sci Rep, 11(1): https:\/\/doi.org\/10.1038\/s41598-020-74399-w","DOI":"10.1038\/s41598-020-74399-w"},{"key":"8023_CR172","doi-asserted-by":"publisher","unstructured":"E. A. Boots et al., (2024) \u201cContinuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer\u2019s Disease\u201d. J Prev Alzheimers Dis, https:\/\/doi.org\/10.14283\/jpad.2024.99","DOI":"10.14283\/jpad.2024.99"},{"issue":"11","key":"8023_CR173","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41583-018-0071-7","volume":"19","author":"SB Eickhoff","year":"2018","unstructured":"Eickhoff SB, Yeo BTT, Genon S (2018) Imaging-based parcellations of the human brain. Nat Rev Neurosci 19(11):672\u2013686. https:\/\/doi.org\/10.1038\/s41583-018-0071-7","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"8023_CR174","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41582-021-00510-y","volume":"17","author":"M Smits","year":"2021","unstructured":"Smits M (2021) MRI biomarkers in neuro-oncology. Nat Rev Neurol 17(8):486\u2013500. https:\/\/doi.org\/10.1038\/s41582-021-00510-y","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"8023_CR175","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/0141076818815510","volume":"112","author":"S Reddy","year":"2019","unstructured":"Reddy S, Fox J, Purohit MP (2019) Artificial intelligence-enabled healthcare delivery. J R Soc Med 112(1):22\u201328. https:\/\/doi.org\/10.1177\/0141076818815510","journal-title":"J R Soc Med"},{"issue":"3","key":"8023_CR176","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.2018180547","volume":"290","author":"S Soffer","year":"2019","unstructured":"Soffer S, Ben-Cohen A, Shimon O, Amitai MM, Greenspan H, Klang E (2019) Convolutional Neural Networks for Radiologic Images: A Radiologist\u2019s Guide. Radiology 290(3):590\u2013606. https:\/\/doi.org\/10.1148\/radiol.2018180547","journal-title":"Radiology"},{"key":"8023_CR177","doi-asserted-by":"publisher","unstructured":"Yao Z et al., (2023) \u201cArtificial intelligence-based diagnosis of Alzheimer\u2019s disease with brain MRI images\u201d. Elsevier Ireland Ltd. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110934","DOI":"10.1016\/j.ejrad.2023.110934"},{"issue":"3","key":"8023_CR178","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s43587-024-00573-8","volume":"4","author":"AS Tang","year":"2024","unstructured":"Tang AS et al (2024) Leveraging electronic health records and knowledge networks for Alzheimer\u2019s disease prediction and sex-specific biological insights. Nat Aging 4(3):379\u2013395. https:\/\/doi.org\/10.1038\/s43587-024-00573-8","journal-title":"Nat Aging"},{"issue":"11","key":"8023_CR179","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1007\/s10072-024-07649-8","volume":"45","author":"T Rudroff","year":"2024","unstructured":"Rudroff T, Rainio O, Kl\u00e9n R (2024) AI for the prediction of early stages of Alzheimer\u2019s disease from neuroimaging biomarkers \u2013 A narrative review of a growing field. Neurol Sci 45(11):5117\u20135127. https:\/\/doi.org\/10.1007\/s10072-024-07649-8","journal-title":"Neurol Sci"},{"issue":"3","key":"8023_CR180","doi-asserted-by":"publisher","first-page":"e180089","DOI":"10.1148\/ryai.2019180089","volume":"1","author":"L Oakden-Rayner","year":"2019","unstructured":"Oakden-Rayner L (2019) The Rebirth of CAD: How Is Modern AI Different from the CAD We Know? Radiol Artif Intell 1(3):e180089. https:\/\/doi.org\/10.1148\/ryai.2019180089","journal-title":"Radiol Artif Intell"},{"issue":"4","key":"8023_CR181","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","volume":"15","author":"SG Mueller","year":"2005","unstructured":"Mueller SG et al (2005) The Alzheimer\u2019s disease neuroimaging initiative. Neuroimaging Clin N Am 15(4):869\u201377. https:\/\/doi.org\/10.1016\/j.nic.2005.09.008","journal-title":"Neuroimaging Clin N Am"},{"issue":"4","key":"8023_CR182","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA (2016) From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15(4):275\u2013292. https:\/\/doi.org\/10.1038\/nrd.2015.21","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"8023_CR183","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","volume":"12","author":"JL Dage","year":"2016","unstructured":"Dage JL et al (2016) Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort. Alzheimer\u2019s & Dementia 12(12):1226\u20131234. https:\/\/doi.org\/10.1016\/j.jalz.2016.06.001","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"6","key":"8023_CR184","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.3390\/ijms23063383","volume":"23","author":"T Biernacki","year":"2022","unstructured":"Biernacki T et al (2022) Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations. Int J Mol Sci 23(6):3383. https:\/\/doi.org\/10.3390\/ijms23063383","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8023_CR185","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/ncomms2593","volume":"4","author":"T Teramoto","year":"2013","unstructured":"Teramoto T et al (2013) Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction. Nat Commun 4(1):1572. https:\/\/doi.org\/10.1038\/ncomms2593","journal-title":"Nat Commun"},{"issue":"7","key":"8023_CR186","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jalz.2018.01.006","volume":"14","author":"SD Stites","year":"2018","unstructured":"Stites SD, Rubright JD, Karlawish J (2018) What features of stigma do the public most commonly attribute to Alzheimer\u2019s disease dementia? Results of a survey of the U.S. general public. Alzheimer\u2019s Dementia 14(7):925\u2013932. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.006","journal-title":"Alzheimer\u2019s Dementia"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08023-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:24:29Z","timestamp":1747376669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08023-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":186,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["8023"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08023-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article is based on previously published studies and does not involve any new studies with human participants or animals conducted by the authors. All referenced studies were conducted by ethical standards, including the 1964 Declaration of Helsinki and its subsequent amendments, as applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare they have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}